Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Neuroendocrine 1

Interventions

Specimen Handling 308 Magnetic Resonance Spectroscopy 265 pembrolizumab 254 Carboplatin 185 Cyclophosphamide 180 Biopsy 168 Cisplatin 157 Gemcitabine 136 Paclitaxel 131 Bevacizumab 125 fludarabine 118 Nivolumab 111 Radiotherapy 109 Oxaliplatin 88 Docetaxel 88 Fluorouracil 85 Capecitabine 84 venetoclax 78 Dexamethasone 77 Pemetrexed 73 Rituximab 70 Leucovorin 69 Drug Therapy 69 durvalumab 67 atezolizumab 67 Radiosurgery 65 Blood Specimen Collection 65 Standard of Care 64 Doxorubicin 64 Radiation 60

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × DLL3 protein, human × 90 days × Clear all

NCT06893783 2026-04-13

DeLLight

Asan Medical Center

Phase 2 Recruiting

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡